Kiniksa Pharmaceuticals International, PLC (KNSA) — 8-K Filings

All 8-K filings from Kiniksa Pharmaceuticals International, PLC. Browse 18 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (18)

Kiniksa Pharmaceuticals 8-K Filing — Sep 3, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc reported on September 3, 2025, that its Class A Ordinary Shares trade under the symbol KNSA on the Nasdaq Global Sele
Kiniksa Pharmaceuticals Files 8-K on Operations — Jul 29, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on July 29, 2025, reporting on its results of operations and financial condition, as well as financial s
Kiniksa Pharmaceuticals Files 8-K — Jun 5, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on June 5, 2025, reporting information under Regulation FD and including financial statements and exhibi
Kiniksa Pharmaceuticals 8-K Filing on Shareholder Votes — Jun 3, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on June 3, 2025, to report on matters submitted to a vote of its security holders. The filing details th
Kiniksa Pharmaceuticals Files 8-K on Financials — Apr 29, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on April 29, 2025, reporting on its results of operations and financial condition. The filing also inclu
Kiniksa Pharma Reports Director/Officer Changes & Compensatory Info — Apr 23, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on April 23, 2025, reporting events as of April 17, 2025. The filing pertains to the departure of direct
Kiniksa Pharmaceuticals Terminates Material Agreement — Feb 25, 2025 Risk: medium
On February 21, 2025, Kiniksa Pharmaceuticals International, plc filed an 8-K reporting the termination of a material definitive agreement. The filing also cove
Kiniksa Pharmaceuticals Files 8-K on Financials — Jan 13, 2025 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on January 13, 2025, reporting on its results of operations and financial condition. The filing includes
Kiniksa Pharmaceuticals Files 8-K on Operations — Oct 29, 2024 Risk: low
Kiniksa Pharmaceuticals International, plc filed an 8-K on October 29, 2024, to report on its results of operations and financial condition, and to file financi
Kiniksa Appoints New CEO, Dr. Sanj K. Patel — Oct 7, 2024 Risk: medium
Kiniksa Pharmaceuticals International, plc announced on October 7, 2024, that Dr. Sanj K. Patel will be appointed as Chief Executive Officer and a member of the
Kiniksa Pharmaceuticals Files 8-K on Operations — Jul 23, 2024 Risk: low
On July 23, 2024, Kiniksa Pharmaceuticals International, plc filed an 8-K report. The filing primarily concerns the company's results of operations and financia
Kiniksa Pharmaceuticals Enters Material Definitive Agreement — Jun 25, 2024 Risk: medium
Kiniksa Pharmaceuticals, Ltd. announced on June 25, 2024, that it has entered into a material definitive agreement. The company, incorporated in Bermuda with it
Kiniksa Pharmaceuticals Files 8-K Report — Jun 14, 2024 Risk: low
On June 14, 2024, Kiniksa Pharmaceuticals, Ltd. filed an 8-K report. The filing indicates that the company is incorporated in Bermuda and provides its principal
Kiniksa Pharmaceuticals Files 8-K on Shareholder Vote Matters — Jun 5, 2024 Risk: low
Kiniksa Pharmaceuticals, Ltd. filed an 8-K on June 5, 2024, to report on the submission of matters to a vote of security holders. The filing does not contain sp
Kiniksa Pharmaceuticals Files 8-K — Apr 2, 2024 Risk: low
Kiniksa Pharmaceuticals, Ltd. filed an 8-K on April 2, 2024, to report on a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not
Kiniksa Pharmaceuticals Files 8-K — Mar 29, 2024 Risk: low
On March 29, 2024, Kiniksa Pharmaceuticals, Ltd. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material
Kiniksa Pharmaceuticals Files 8-K on Financial Condition — Feb 28, 2024 Risk: low
Kiniksa Pharmaceuticals, Ltd. filed an 8-K on February 28, 2024, regarding its results of operations and financial condition. This filing indicates the company
Kiniksa Pharma Files 8-K on Operations & Financial Condition — Jan 4, 2024
Kiniksa Pharmaceuticals, Ltd. filed an 8-K on January 4, 2024, to report on its results of operations and financial condition, as well as to make a Regulation F

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX